Estrella Immunopharma, Inc. (ESLA) stock
ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)
Close on Nov 17, 2026Market cap $14.42MP/E –Yield –
Estrella Immunopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Estrella Immunopharma's price to book ratio was 6.1× on Jul 31, 2026, against 7.2× a year earlier. Over the last 3 years it ranged from 3.9× to 20.7×, with a median of 8.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 6.1× | −7.2 |
| 2025 | Dec 31, 2025 | 13.4× | +3.1 |
| 2024 | Dec 31, 2024 | 10.3× | +6.4 |
| 2023 | Dec 29, 2023 | 3.9× | – |
See a number that looks wrong?